Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Bernie Sanders wants to add price caps to therapies developed with BARDA, CDC funds
Last year
FDA+
Amgen and Horizon call FTC's attempt to block $28B merger unconstitutional in counterclaims
Last year
Pharma
CSPC to launch Paxlovid version in China; SEC charges ex-Pfizer employee with insider trading
Last year
China
Coronavirus
CMS reworks drug price negotiation process with lawsuits top of mind
Last year
Judge in Astellas patent suit denies motion to bolster defendant’s case
Last year
Pharma
'Continue laying golden eggs!': Pharma exec, doctors charged by SEC for alleged insider trading around Alexion-Portola deal
Last year
People
Regenxbio, UPenn file patent suit against Sarepta related to new Duchenne gene therapy
Last year
GSK settles key Zantac case ahead of trial
Last year
Pharma
Jazz sues FDA, HHS over rival narcolepsy drug approval
Last year
Pharma
US government challenges jury decision in Gilead HIV patent trial
Last year
Pharma
PhRMA joins Merck and BMS in suing over Medicare drug price negotiations
Last year
Tribunal dismisses Boehringer Ingelheim's liability claim against Sanofi in Zantac case
Last year
Pharma
Q&A with Genentech CEO Alexander Hardy on Medicare's drug price negotiations
Last year
People
Bristol Myers joins the legal fight over incoming Medicare drug price negotiations
Last year
AbbVie's Pharmacyclics files patent suit against BeiGene over BTK rival Brukinsa
Last year
Pharma
House Republicans use FDA appropriations bill to override REMS changes on abortion pill
Last year
FDA+
Congress introduces two new bills about PBM reform, drug pricing
Last year
Pharma
Merck gets a patent win for muscle relaxant reversal drug
Last year
Pharma
IRA side effect: Pharma companies will increasingly skip Medicare altogether, Lilly CEO says
Last year
Pharma
Astellas loses patent infringement case over blockbuster bladder drug
Last year
Pharma
US Chamber of Commerce files second suit over Medicare's incoming drug price negotiations
Last year
Second round of inflation-related rebates hits 43 drugs from Amgen, Seagen, AbbVie and others
Last year
Pharma
Tiny biotech takes on mRNA vaccine juggernauts in federal court in patent infringement cases
Last year
Pharma
Merck sued the US to block the drug pricing law. Will other pharma companies follow suit?
Last year
Pharma
First page
Previous page
18
19
20
21
22
23
24
Next page
Last page